Background to the report
Under the NHS Constitution, NHS patients have the right to receive consultant-led elective (non-urgent) treatment within 18 weeks of being referred for treatment (usually by a GP), unless they choose to wait longer, or it is clinically appropriate to do so. For urgent referrals for suspected cancer, patients have the right to be seen by a cancer specialist within two weeks. The government has pledged that patients should wait a maximum of 62 days from urgent referral for suspected cancer to first treatment for all cancers. To ensure patients’ rights to timely access to care, the Department of Health & Social Care has set various waiting times performance standards. These describe the percentage of patients that NHS bodies must treat within maximum waiting times. Three-quarters of outpatient referrals, as well as many admissions to hospital, are covered by waiting times standards for non-urgent (elective) and cancer care.Jump to downloads
Content and scope of the report
This review presents data on the NHS’s performance against current waiting times standards for elective and cancer care in England, and some of the factors associated with that performance. It draws together existing evidence and analysis by the Department, NHS England, NHS Improvement and other stakeholders. We build on this evidence base with our own analysis to provide added insight into:
- changes in waiting times performance, and variations in that performance;
- the impact of waiting times performance on patients;
- the factors that influence waiting times performance; and
- NHS England’s and NHS Improvement’s approach to managing and improving waiting times performance.
At a time of financial restraint, the NHS has responded to growing demand for elective and cancer care by increasing the amount of treatment it provides. However, this has not been sufficient to maintain performance against waiting times standards, and some standards have not been met for some years. Cancer performance has been affected by increasing referrals resulting from the desirable choice to improve early diagnosis and survival rates. While increased demand and funding constraints affect the entire system, other factors are linked with differences in performance both over time and across trusts. These include staff shortages for diagnostic services, a lack of available beds, inefficient processes and, in some cases, patient choices. The NHS Long Term Plan commits to reducing face-to-face outpatient visits by one-third. Such a reduction would have a significant impact on elective care performance, as it is currently measured. The plan also commits to increasing the proportion of patients diagnosed with cancer at early stages from 50% to 75% by 2028. The NHS is now preparing local implementation plans for these new commitments. It is hard to see how the NHS will be able to recover its position on waiting times in the near future without significant investment in staffing and infrastructure.
“The NHS’s actions to increase the number of urgent cancer referrals are a positive step. They have helped to diagnose more patients at earlier stages, leading to better outcomes, even though this has meant that waiting times commitments for cancer care are no longer being met. “However, there has been insufficient progress on tackling or understanding the reasons behind the increasing number of patients now waiting longer for non-urgent care. With rising demand for care as well as constraints in capacity, it is hard to see how the NHS will be able to turn around this position without significant investment in additional staffing and infrastructure.”Amyas Morse, the head of the NAO
- Full report - NHS waiting times for elective and cancer treatment (.pdf — 897 KB)
- Summary - NHS waiting times for elective and cancer treatment (.pdf — 107 KB)
- ePub - NHS waiting times for elective and cancer treatment (.epub — 3 MB)
- ISBN: 9781786042538 [Buy a hard copy of this report]
- HC: 1989, 2017-19
View press release (22 Mar 2019)